Literature DB >> 25257665

Diagnosis of pediatric hyperthyroidism: technetium 99 uptake versus thyroid stimulating immunoglobulins.

Charumathi Baskaran1, Madhusmita Misra, Lynne L Levitsky.   

Abstract

BACKGROUND: Treatment with antithyroid drugs is effective in conditions of increased thyroid hormone production (mostly Graves' Disease; GD), but not in subacute thyroiditis (SAT) or autoimmune thyroiditis (AIT). Positive thyroid stimulating immunoglobulins (TSI) make GD likely. However, not all children with GD have increased TSI. Uptake studies with (123)I or (99)Tc ((99m)Tc) provide accurate and rapid diagnosis but are expensive and involve radiation exposure. Our objective was to compare TSI with (99m)Tc uptake for diagnosis of pediatric hyperthyroidism.
METHODS: We performed a retrospective chart review of hyperthyroid children who had both TSI estimation and (99m)Tc uptake assessment at presentation. Based on subsequent laboratory studies and follow-up, 37 had GD and 10 had non-GD thyroiditis. The TSI index was considered positive (TSI+) when it was above the upper limit of normal. (99m)Tc uptake was considered positive (Tc+) for any uptake >0.4% and negative (and low) (Tc-) for uptake ≤0.4%.
RESULTS: Forty-seven youth (83% females), aged 12.3±4.6 years, presented with a suppressed thyrotropin (TSH) and elevated free thyroxine and total triiodothyronine. All 37 patients with GD were Tc+ (100% sensitivity and specificity). The sensitivity of TSI for diagnosing GD was 84%, and the specificity was 100%. Six patients with GD were discordant with Tc+ but TSI-. Elevated TSI correlated with Tc+ (p=0.01) with a degree of agreement (kappa) of 0.69.
CONCLUSION: (99m)Tc has excellent specificity and sensitivity in diagnosing GD. Given additional costs of (99m)Tc (two and a half times as much as TSI), it is reasonable to reserve (99m)Tc uptake assessment for hyperthyroidism of unclear etiology and negative TSI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25257665      PMCID: PMC4291090          DOI: 10.1089/thy.2014.0266

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  13 in total

1.  Analysis of the factors associated with Tc-99m pertechnetate uptake in thyrotoxicosis and graves' disease.

Authors:  Yo Kidokoro-Kunii; Naoya Emoto; Keiichi Cho; Shinichi Oikawa
Journal:  J Nippon Med Sch       Date:  2006-02       Impact factor: 0.920

2.  Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves disease.

Authors:  D Botero; R S Brown
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

3.  Procedure guideline for thyroid scintigraphy: 1.0. Society of Nuclear Medicine.

Authors:  D Becker; N D Charles; H Dworkin; J Hurley; I R McDougall; D Price; H Royal; S Sarkar
Journal:  J Nucl Med       Date:  1996-07       Impact factor: 10.057

4.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.

Authors:  Rebecca S Bahn; Henry B Burch; David S Cooper; Jeffrey R Garber; M Carol Greenlee; Irwin Klein; Peter Laurberg; I Ross McDougall; Victor M Montori; Scott A Rivkees; Douglas S Ross; Julie Ann Sosa; Marius N Stan
Journal:  Endocr Pract       Date:  2011 May-Jun       Impact factor: 3.443

5.  Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system.

Authors:  Keiichi Kamijo
Journal:  Endocr J       Date:  2010-08-12       Impact factor: 2.349

6.  Thyroid stimulating immunoglobulin is often negative in children with Graves' disease.

Authors:  Samar N Rahhal; Erica A Eugster
Journal:  J Pediatr Endocrinol Metab       Date:  2008-11       Impact factor: 1.634

7.  Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease.

Authors:  Olga M Acuna; Ioanna Athannassaki; Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2007

8.  Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.

Authors:  J C Morris; I D Hay; R E Nelson; N S Jiang
Journal:  Mayo Clin Proc       Date:  1988-07       Impact factor: 7.616

9.  Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism.

Authors:  L Giovanella; L Ceriani; A Ghelfo
Journal:  Horm Metab Res       Date:  2008-03-31       Impact factor: 2.936

10.  Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.

Authors:  T Mukuta; H Tamai; A Oshima; T Morita; S Matsubayashi; S Fukata; K Kuma
Journal:  Clin Endocrinol (Oxf)       Date:  1994-02       Impact factor: 3.478

View more
  2 in total

1.  Comparison of 99mTc Pertechnetate Thyroid Uptake Rates by Gamma Probe and Gamma Camera Methods for Differentiating Graves' Disease and Thyroiditis.

Authors:  Meihua Jin; Jonghwa Ahn; Seong-Gil Jo; Jangwon Park; Min Ji Jeon; Won Gu Kim; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2022-01-07

2.  Cut off value of technetium uptake in the differential diagnosis of Graves, disease and subacute thyroiditis.

Authors:  Demir Fadime
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.